6.
Gilbert R, Metcalfe C, Fraser W, Donovan J, Hamdy F, Neal D
. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade. Cancer Causes Control. 2012; 23(11):1865-73.
DOI: 10.1007/s10552-012-0052-5.
View
7.
Anderson P, Turner A, Morris H
. Vitamin D actions to regulate calcium and skeletal homeostasis. Clin Biochem. 2012; 45(12):880-6.
DOI: 10.1016/j.clinbiochem.2012.02.020.
View
8.
Jean G, Souberbielle J, Chazot C
. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients. 2017; 9(4).
PMC: 5409667.
DOI: 10.3390/nu9040328.
View
9.
Smith K, Thompson P, Rodriguez E, Mackay L, Cobice D
. Effects of vitamin D as a regulator of androgen intracrinology in LNCAP prostate cancer cells. Biochem Biophys Res Commun. 2019; 519(3):579-584.
DOI: 10.1016/j.bbrc.2019.09.059.
View
10.
Mottet N, van den Bergh R, Briers E, Van den Broeck T, Cumberbatch M, De Santis M
. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2020; 79(2):243-262.
DOI: 10.1016/j.eururo.2020.09.042.
View
11.
Reichrath J, Marz W, de Gruijl F, Vieth R, Grant W, Slominski A
. An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act!. Anticancer Res. 2022; 42(10):5009-5015.
DOI: 10.21873/anticanres.16008.
View
12.
Chandler P, Giovannucci E, Scott J, Bennett G, Ng K, Chan A
. Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial. Cancer Epidemiol Biomarkers Prev. 2014; 23(9):1944-7.
PMC: 4167903.
DOI: 10.1158/1055-9965.EPI-14-0522.
View
13.
Bikle D
. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014; 21(3):319-29.
PMC: 3968073.
DOI: 10.1016/j.chembiol.2013.12.016.
View
14.
Jiang X, Dimou N, Al-Dabhani K, Lewis S, Martin R, Haycock P
. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol. 2019; 48(5):1416-1424.
PMC: 6934026.
DOI: 10.1093/ije/dyy284.
View
15.
Kristal A, Till C, Song X, Tangen C, Goodman P, Neuhauser M
. Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2014; 23(8):1494-504.
PMC: 4119495.
DOI: 10.1158/1055-9965.EPI-14-0115.
View
16.
Filella X, Alcover J, Molina R, Rodriguez A, Carretero P, Ballesta A
. Free and total PSA in the diagnosis of prostate cancer. Tumour Biol. 1997; 18(6):332-40.
DOI: 10.1159/000218047.
View
17.
Vicentini F, Botelho L, Hisano M, Ebaid G, Lucon M, Lucon A
. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men?. Urology. 2009; 73(5):1032-5.
DOI: 10.1016/j.urology.2009.01.015.
View
18.
Makris K, Bhattoa H, Cavalier E, Phinney K, Sempos C, Ulmer C
. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism. Clin Chim Acta. 2021; 517:171-197.
PMC: 8080555.
DOI: 10.1016/j.cca.2021.03.002.
View
19.
Toprak B, Colak A, Yalcin H, Yildirim M
. No association of serum PSA with vitamin D or total oxidant-antioxidant capacity in healthy men. Aging Male. 2018; 22(3):214-217.
DOI: 10.1080/13685538.2018.1491026.
View
20.
Grant W
. Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer. Anticancer Res. 2020; 40(1):491-499.
DOI: 10.21873/anticanres.13977.
View